Neratinib as extended adjuvant therapy in patients with HER2-positive/HR-positive early breast cancer: German HTA-driven analyses from the ExteNET study

by D. Lüftner, H. Tesch, M. Schmidt, A. Hartkopf, S. Streicher, A. Resch, L. Genovese, C. Rosé, R. Valenti, N. Harbeck
Published 2021-04-01

ViBiBa: Virtual BioBanking for the DETECT multicenter trial program - decentralized storage and processing

by H. Asperger, J.-P. Cieslik, B. Alberter, C. Köstler, B. Polzer, V. Müller, K. Pantel, S. Riethdorf, A. Koch, A. Hartkopf, L. Wiesmüller, W. Janni, F. Schochter, A. Franken, D. Niederacher, T. Fehm, H. Neubauer
Published 2021-08-01